Integra Lifesciences Fair Value
IL
The fair market value of IL3.F stock is 9.23 EUR. Relative to the market price of 17.1 EUR Integra Lifesciences is overvalued by 47.8%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Integra Lifesciences Valuation
Current IL3.F share ticker price is 17.1 EUR.
The fair value level of 9.23 EUR can be considered as an effective entry point for long-term investors to start investing in IL3.F stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 46% higher its fair value
Current price is 58% higher its minimum value
Current price is 45% lower its maximum value
Market price:
IL3.F stock is overvalued
It means the current price may concern as a Risky Entry Point
Integra Lifesciences Holdings Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
91.36
2
Median P/E over 5 years
34.11
3
Minimum P/E over 5 years
26.35
4
Earning per share (last 12 months)
0.29 USD
Maximum value
1
x
4
=
24.73 EUR
Fair value
2
x
4
=
9.23 EUR
Minimum value
3
x
4
=
7.13 EUR
Integra Lifesciences Holdings Corp price metrics
-19.86
Annual return (geometric mean)
37.64
Risk (standard deviation) of returns
β
1.42
Beta (volatility compared to market)